(Geneva - May 15, 2008) On the eve of the 61st World Health Assembly, patient representatives from around the world gathered in Geneva to voice their concerns and provide recommendations on the WHO’s proposed strategy and draft plan of action on public health, innovation and intellectual property.
(IAPO Press Release - May 1, 2008) The International Alliance of Patient’s Organizations (IAPO) took the opportunity to call on WHO member states to engage patients in the development of the draft plan of action on Public Health, Innovation and Intellectual Property.
(Afrik.com - Apr. 30, 2008) Many important steps need to be to taken to improve medical care in the Third World. Despite what the health activists are saying, stealing drug patents and stifling the creation of life-saving medicines is not one of them. What patients need aren’t patent-busting bureaucrats, but more roads, doctors, hospitals, nutritious food, and good sanitation.
(The Daily Times, Malawi - Apr. 30, 2008) A new breed of Western colonialists has emerged in Africa. These statist NGOs support ideologies proven not to work in their own countries. Amongst other agendas, they want bureaucrats rather than markets to determine what diseases are researched. Before taking their medicine, we must carefully read the label or suffer nasty side effects.
(Essential Innovation - Apr. 30, 2008) The IGWG should focus on mechanisms that complement the existing system of medical research and development -- and address real barriers to access such as poverty, taxes and corruption -- rather than engineering a replacement to the current intellectual property rights regime.
(The New Times, Kigali - Apr. 28, 2008) The anti-patent crowd believes that patents keep prices high and drugs out of the reach of the poor. But even if medicine were available for free, as it often is in poor nations, dysfunctional institutions and personnel ensure that the needy can't access it.
(CIOL.com - Apr. 23, 2008) To achieve environmental, social and economic progress, humanity needs to innovate. Despite this, there has been a global campaign to undermine IP rights by a group of anti-market activists, self-interested politicians, vested interests, and more recently, the infiltrated World Health Organisation.
(The American - Apr. 16, 2008) Establishing a new global bureaucracy to regulate drug research and development would be highly counterproductive. The WHO risks scaring away those entities in the best position to engage in risky and expensive drug research: big pharmaceutical companies.
Siguiente » 1 2 3 4 5